Glycomimetic peptides as powerful anti-inflammatory treatments

Glycan (sugar)-binding lectin-type receptors on immune cells have the potential to serve as therapeutic targets. However, many of these receptors are not targeted because of a lack of suitable binding agents. Professor J Kenneth Hoober and Dr Laura L Eggink, co-founders of Susavion Biosciences, Inc, and Wild Boar Biosciences, LLC, have created peptide mimetics of glycans that show greater flexibility […]

Read More… from Glycomimetic peptides as powerful anti-inflammatory treatments

Computational biology: How mathematical modelling can help cure cancer

Susan Mertins uses computational modelling to build virtual cells and machine learning to develop new approaches to treating cancer.

Understanding how living cells work is difficult due to the number of varied and complex processes occurring in them. This complexity can be elucidated by breaking these processes down into simpler components and focusing on a particular mechanism. One approach to this study is to use mathematical equations – the basis of computational modelling. Dr Susan Mertins, the founder and […]

Read More… from Computational biology: How mathematical modelling can help cure cancer